Cardiovascular Disease in End-stage Renal Failure
|von Joseph Loscalzo|
Synopsis A better understanding of the pathophysiology of renal failure coupled with technological advances in dialysis techniques and renal transplantation have greatly improved the prognosis and survival for patients with end-stage renal disease (ESRD). The advances and success of treatment are limited by a number of extrarenal complications that can cause significant morbidity and mortality. Of these, cardiovascular abnormalities are the most common, with cardiac complications alone accounting for more than 40 per cent of deaths in international registries. The importance of cardiovascular complications has become more apparent with the increased prevalence of diabetes mellitus and vascular nephropathy and with the general ageing of patients with ESRD. The 1990s have witnessed enormous advances in understanding the causes and pathophysiology of cardiovascular disease, and their diagnosis, treatment, and prevention.
Nephrologie > Cardiovascular Disease in End-stage Renal Failure|